Your browser is no longer supported. Please, upgrade your browser.
AXDX Accelerate Diagnostics, Inc. daily Stock Chart
Accelerate Diagnostics, Inc.
Index- P/E- EPS (ttm)-1.54 Insider Own3.80% Shs Outstand54.84M Perf Week-5.90%
Market Cap769.53M Forward P/E- EPS next Y-1.13 Insider Trans154.70% Shs Float32.17M Perf Month-16.11%
Income-83.90M PEG- EPS next Q-0.34 Inst Own53.90% Short Float49.01% Perf Quarter52.84%
Sales9.90M P/S77.73 EPS this Y4.60% Inst Trans-2.10% Short Ratio34.13 Perf Half Y-12.10%
Book/sh-0.42 P/B- EPS next Y22.00% ROA-60.20% Target Price13.50 Perf Year-20.78%
Cash/sh1.76 P/C8.36 EPS next 5Y30.00% ROE- 52W Range4.53 - 22.13 Perf YTD-13.14%
Dividend- P/FCF- EPS past 5Y-16.90% ROI-59.30% 52W High-31.99% Beta2.75
Dividend %- Quick Ratio14.70 Sales past 5Y137.90% Gross Margin46.70% 52W Low232.23% ATR1.31
Employees275 Current Ratio16.00 Sales Q/Q27.80% Oper. Margin- RSI (14)50.35 Volatility10.24% 8.14%
OptionableYes Debt/Eq- EPS Q/Q2.80% Profit Margin- Rel Volume0.25 Prev Close14.68
ShortableYes LT Debt/Eq- EarningsAug 06 AMC Payout- Avg Volume461.88K Price15.05
Recom2.50 SMA20-4.04% SMA506.87% SMA20011.66% Volume27,015 Change2.52%
Aug-07-20Upgrade Craig Hallum Hold → Buy $20
Sep-27-19Downgrade JP Morgan Neutral → Underweight $16
Nov-07-18Downgrade JP Morgan Overweight → Neutral
May-24-18Initiated Craig Hallum Hold $25
Dec-13-17Downgrade BTIG Research Buy → Neutral
Jul-12-17Resumed BTIG Research Buy $34
Mar-24-16Initiated JP Morgan Overweight $17
Dec-16-15Initiated Piper Jaffray Overweight
Jul-30-20 12:33PM  
Jul-17-20 07:00AM  
Jul-16-20 08:00AM  
Jun-25-20 06:26PM  
Jun-15-20 09:20AM  
May-29-20 12:00PM  
May-26-20 08:51AM  
May-21-20 04:06PM  
May-09-20 10:00PM  
May-07-20 04:01PM  
Apr-30-20 12:34PM  
Apr-28-20 08:00AM  
Apr-22-20 12:00PM  
Apr-16-20 05:26PM  
Apr-15-20 05:08PM  
Apr-01-20 03:30PM  
Mar-07-20 12:26AM  
Feb-29-20 07:38AM  
Feb-20-20 12:31PM  
Feb-18-20 01:48PM  
Feb-11-20 12:30PM  
Jan-13-20 01:00AM  
Jan-03-20 04:01PM  
Dec-24-19 01:08PM  
Dec-08-19 03:00PM  
Dec-04-19 11:11AM  
Dec-02-19 10:08AM  
Nov-25-19 09:08PM  
Nov-18-19 10:04AM  
Nov-08-19 04:30PM  
Nov-07-19 06:25PM  
Nov-04-19 07:45AM  
Oct-31-19 10:34AM  
Oct-28-19 06:15PM  
Oct-17-19 08:00AM  
Oct-03-19 08:00AM  
Sep-19-19 08:00AM  
Sep-18-19 10:20AM  
Aug-14-19 09:00PM  
Aug-12-19 12:48PM  
Aug-09-19 02:24AM  
Aug-08-19 06:05PM  
Aug-05-19 12:18PM  
Aug-01-19 10:33AM  
Jul-15-19 02:15PM  
Jul-08-19 08:30AM  
Jun-19-19 03:41PM  
May-24-19 12:45PM  
May-22-19 12:56PM  
May-10-19 01:23PM  
May-09-19 06:05PM  
May-08-19 04:05PM  
May-02-19 10:32AM  
Apr-26-19 11:44AM  
Apr-16-19 12:09PM  
Apr-05-19 07:22PM  
Mar-08-19 03:38PM  
Mar-01-19 07:48AM  
Feb-26-19 08:25AM  
Feb-21-19 07:28AM  
Feb-19-19 08:05PM  
Feb-12-19 10:30AM  
Feb-08-19 07:50AM  
Feb-05-19 04:03PM  
Jan-02-19 04:48PM  
Dec-26-18 10:36AM  
Nov-27-18 07:12AM  
Nov-09-18 07:45AM  
Nov-06-18 06:15PM  
Oct-30-18 10:33AM  
Oct-17-18 04:51PM  
Oct-15-18 09:20AM  
Oct-08-18 08:53AM  
Sep-27-18 04:01PM  
Aug-19-18 11:45PM  
Aug-08-18 07:45AM  
Aug-07-18 07:50AM  
Aug-06-18 05:20PM  
Jul-19-18 02:30PM  
Jun-25-18 02:32PM  
Jun-05-18 11:30AM  
Accelerate Diagnostics, Inc., an in vitro diagnostics company, provides solutions for the diagnosis of serious infections in the United States, Europe, and the Middle East. It offers Accelerate Pheno system, an in vitro diagnostic platform for the identification and antibiotic susceptibility testing of pathogens associated with serious or health care-associated infections, including gram-positive and gram-negative organisms, as well as yeast. The company was formerly known as Accelr8 Technology Corporation and changed its name to Accelerate Diagnostics, Inc. in December 2012. Accelerate Diagnostics, Inc. was founded in 1982 and is headquartered in Tucson, Arizona.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
HUMPHRIES ROMNEYChief Scientific OfficerJun 18Option Exercise5.933,00017,7903,000Jun 22 07:26 PM
HUMPHRIES ROMNEYChief Scientific OfficerJun 18Sale12.003,00036,0000Jun 22 07:26 PM
HUMPHRIES ROMNEYChief Scientific OfficerJun 17Option Exercise5.932,00011,8602,000Jun 22 07:26 PM
HUMPHRIES ROMNEYChief Scientific OfficerJun 17Sale11.752,00023,5000Jun 22 07:26 PM
HUMPHRIES ROMNEYChief Scientific OfficerJun 16Option Exercise5.934,00023,7204,000Jun 22 07:26 PM
HUMPHRIES ROMNEYChief Scientific OfficerJun 16Sale11.004,00044,0000Jun 22 07:26 PM
SCHULER JACK WDirectorJun 15Buy9.8695,492941,55116,603,524Jun 17 03:30 PM
SCHULER JACK WDirectorJun 12Buy9.34134,0801,252,30716,508,032Jun 16 03:32 PM
SCHULER JACK WDirectorJun 11Buy9.18129,0001,184,22016,373,952Jun 15 03:35 PM
SCHULER JACK WDirectorJun 10Buy9.84100,000984,00016,244,952Jun 12 03:28 PM
SCHULER JACK WDirectorJun 09Buy9.63180,9551,742,59716,144,952Jun 11 03:36 PM
SCHULER JACK WDirectorJun 05Buy8.581,100,0009,438,00015,963,997Jun 09 02:49 PM
SCHULER JACK WDirectorMay 13Buy9.4689,055842,46014,863,997May 15 04:21 PM
SCHULER JACK WDirectorMay 12Buy9.9220,000198,40014,774,942May 14 03:39 PM
SCHULER JACK WDirectorMay 11Buy9.9920,000199,80014,754,942May 13 03:18 PM
SCHULER JACK WDirectorMay 07Buy9.8725,000246,75014,734,942May 11 03:44 PM
SCHULER JACK WDirectorMay 06Buy10.0010,868108,68014,709,942May 08 03:00 PM
SCHULER JACK WDirectorMay 05Buy10.008,62586,25014,699,074May 07 04:19 PM
SCHULER JACK WDirectorMay 04Buy9.981,20412,01614,690,449May 06 03:29 PM
SCHULER JACK WDirectorMay 01Buy10.034,00040,12014,689,245May 05 03:21 PM
SCHULER JACK WDirectorApr 24Buy10.005,00150,01014,685,245Apr 28 03:40 PM
SCHULER JACK WDirectorApr 23Buy9.9081,621808,04814,680,244Apr 27 03:25 PM
SCHULER JACK WDirectorApr 22Buy9.47157,6881,493,30514,598,623Apr 24 03:39 PM
SCHULER JACK WDirectorApr 21Buy9.0179,650717,64714,440,935Apr 23 03:36 PM
SCHULER JACK WDirectorApr 20Buy9.4059,357557,95614,361,285Apr 22 03:17 PM
SCHULER JACK WDirectorMar 31Buy8.30120,000996,00014,301,928Apr 02 03:17 PM
SCHULER JACK WDirectorMar 30Buy8.5980,000687,20014,181,928Apr 01 05:09 PM
SCHULER JACK WDirectorMar 27Buy8.09101,963824,88114,101,928Mar 31 03:12 PM
SCHULER JACK WDirectorMar 26Buy8.04148,0371,190,21713,999,965Mar 30 03:31 PM
SCHULER JACK WDirectorMar 25Buy7.70150,0001,155,00013,851,928Mar 27 09:32 PM
PATIENCE JOHNDirectorMar 24Buy6.835,00034,1504,196,211Mar 26 03:35 PM
SCHULER JACK WDirectorMar 23Buy5.89172,9001,018,38113,551,928Mar 25 03:30 PM
REICHLING STEVENChief Financial OfficerMar 19Buy6.921,0006,92013,300Mar 19 04:05 PM
Strobeck MatthewDirectorMar 18Buy7.1110,00071,100148,235Mar 20 12:31 PM
REICHLING STEVENChief Financial OfficerFeb 27Option Exercise2.9810,00029,80012,300Mar 02 04:55 PM